Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Harmsen

Showing results (81-90 of 270) with videos related to

Pageof 27
Sort By:
Clinical and Experimental Dental Research|November 4, 2024
Does Fusobacterium in Colorectal Cancer Sites Originate From the Oral Cavity? A Pilot StudyNiels Plomp, Kristina Bertl, Marie-Louise Lydrup, et al.
Frontiers in Veterinary Science|January 26, 2023
Mapping of foot-and-mouth disease virus antigenic sites recognized by single-domain antibodies reveals different 146S particle specific sites and particle flexibilityMichiel M Harmsen, Haozhou Li, Shiqi Sun, et al.
Atherosclerosis Plus|January 15, 2024
Plasma lipids in Pseudoxanthoma Elasticum (PXE) patients: A comparative study with population-based reference values and Non-PXE controlsIris M Harmsen, Frank L J Visseren, Madeleine Kok, et al.
International Journal of Systematic and Evolutionary Microbiology|January 2, 2003
Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. novSylvia H Duncan, Georgina L Hold, Hermie J M Harmsen, et al.
Current Opinion in Supportive and Palliative Care|April 24, 2020
Pitfalls and novel experimental approaches to optimize microbial interventions for chemotherapy-induced gastrointestinal mucositisAna R da Silva Ferreira, Hannah R Wardill, Wim J E Tissing, et al.
Archives of Virology|January 1, 1988
Prophylaxis and therapy of virulent encephalomyocarditis virus infection in mice by monoclonal antibodies. Brief reportF Vlaspolder, C A Kraaijeveld, R van Buuren, et al.
International Archives of Allergy and Applied Immunology|January 1, 1986
Potentiation of the cellular immune response by adjuvants: a limited role for adjuvant induced interferonC A Kraaijeveld, W Kamphuis, B J Benaissa-Trouw, et al.
Journal of Virology|October 1, 1993
Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virusI M Fernández, A Snijders, B J Benaissa-Trouw, et al.
Journal of Bacteriology|July 9, 2014
Functional metabolic map of Faecalibacterium prausnitzii, a beneficial human gut microbeAlmut Heinken, M Tanweer Khan, Giuseppe Paglia, et al.
Archives of Virology|January 1, 1988
Discrimination of the determinant specificity of two competitive Semliki Forest virus neutralizing monoclonal antibodies by anti-idiotypic antibodiesT A Oosterlaken, C A Kraaijeveld, A Snijders, et al.
Pageof 27

Showing results (81-90 of 270) with videos related to

Sort By:
Pageof 27
Clinical and Experimental Dental Research|November 4, 2024
Does Fusobacterium in Colorectal Cancer Sites Originate From the Oral Cavity? A Pilot StudyNiels Plomp, Kristina Bertl, Marie-Louise Lydrup, et al.
Frontiers in Veterinary Science|January 26, 2023
Mapping of foot-and-mouth disease virus antigenic sites recognized by single-domain antibodies reveals different 146S particle specific sites and particle flexibilityMichiel M Harmsen, Haozhou Li, Shiqi Sun, et al.
Atherosclerosis Plus|January 15, 2024
Plasma lipids in Pseudoxanthoma Elasticum (PXE) patients: A comparative study with population-based reference values and Non-PXE controlsIris M Harmsen, Frank L J Visseren, Madeleine Kok, et al.
International Journal of Systematic and Evolutionary Microbiology|January 2, 2003
Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. novSylvia H Duncan, Georgina L Hold, Hermie J M Harmsen, et al.
Current Opinion in Supportive and Palliative Care|April 24, 2020
Pitfalls and novel experimental approaches to optimize microbial interventions for chemotherapy-induced gastrointestinal mucositisAna R da Silva Ferreira, Hannah R Wardill, Wim J E Tissing, et al.
Archives of Virology|January 1, 1988
Prophylaxis and therapy of virulent encephalomyocarditis virus infection in mice by monoclonal antibodies. Brief reportF Vlaspolder, C A Kraaijeveld, R van Buuren, et al.
International Archives of Allergy and Applied Immunology|January 1, 1986
Potentiation of the cellular immune response by adjuvants: a limited role for adjuvant induced interferonC A Kraaijeveld, W Kamphuis, B J Benaissa-Trouw, et al.
Journal of Virology|October 1, 1993
Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virusI M Fernández, A Snijders, B J Benaissa-Trouw, et al.
Journal of Bacteriology|July 9, 2014
Functional metabolic map of Faecalibacterium prausnitzii, a beneficial human gut microbeAlmut Heinken, M Tanweer Khan, Giuseppe Paglia, et al.
Archives of Virology|January 1, 1988
Discrimination of the determinant specificity of two competitive Semliki Forest virus neutralizing monoclonal antibodies by anti-idiotypic antibodiesT A Oosterlaken, C A Kraaijeveld, A Snijders, et al.
Pageof 27